InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,180.74
(
1.03%
)
US TECH 100
17,584.40
(
-0.15%
)
Dow Jones
38,852.27
(
0.46%
)
Brent Oil
82.93
(
-0.66%
)
Bitcoin
64,029.12
(
1.36%
)
Post# of 1148
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Report Keyboard Shortcuts
Prev Next

DPep

Send PM Follow Ignore
Followers 0
Posts 232
Boards Moderated 0
Alias Born 12/18/2020

DPep

Re: None

Wednesday, 04/28/2021 11:06:09 AM

Wednesday, April 28, 2021 11:06:09 AM

Post# of 1148
Yes,
Biotech with no products after phase 2 testing went bad. Original company Alteon. Lost a lot of money on bad rumors.
Drug being pushed was supposed to reverse effects of aging and diabetes neuropathy.

I still have 50 shares which is an awesome reminder not to listen to rumors and unsubstantiated hype.

I can't even tell if they are in business - no website to be found.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Report Keyboard Shortcuts
Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news
Only $200 per official company press release!